日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial

作者更正:一线改良FOLFOX方案联合/不联合纳武利尤单抗和伊匹木单抗或FLOT方案联合纳武利尤单抗治疗晚期胃食管腺癌:一项II期多队列IKF-AIO-MOONLIGHT试验

Lorenzen, Sylvie; Goetze, Thorsten Oliver; Thuss-Patience, Peter C; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Hofheinz, Ralf Dieter; Luley, Kim Barbara; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Heinemann, Volker; Angermeier, Stefan; Bolling, Claus; Loose, Maria; Junge, Sabine; Pauligk, Claudia; Al-Batran, Salah-Eddin

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial

一线改良FOLFOX方案联合/不联合纳武利尤单抗和伊匹木单抗或FLOT方案联合纳武利尤单抗治疗晚期胃食管腺癌:一项II期多队列试验

Lorenzen, Sylvie; Goetze, Thorsten Oliver; Thuss-Patience, Peter C; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Hofheinz, Ralf Dieter; Luley, Kim Barbara; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Heinemann, Volker; Angermeier, Stefan; Bolling, Claus; Loose, Maria; Junge, Sabine; Pauligk, Claudia; Al-Batran, Salah-Eddin

Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma

KEYNOTE-585研究中生存期的替代终点:新辅助/辅助帕博利珠单抗联合化疗与安慰剂联合化疗治疗胃癌或胃食管交界处腺癌的比较

Shitara, K; Bang, Y-J; Wyrwicz, L S; Rha, S Y; Oshima, T; Pietrantonio, F; Park, Y-K; Lonardi, S; Yañez, P; Yen, C-J; Metges, J-P; Garrido, M; Moehler, M; Pelles-Avraham, S; Yong, W P; Spallanzani, A; Jensen, E; Krishnan, R; Shih, C-S; Al-Batran, S-E

Comparative Evaluation of Solid-phase and Membrane Mimetic Strategies in Membrane Proteome Coverage and Disease-State Analysis

膜蛋白组覆盖率和疾病状态分析中固相和膜模拟策略的比较评价

Antony, Frank; Bhattacharya, Ashim; Aoki, Hiroyuki; Jandu, Rupinder S; Abdualkader, Abdualrahman M; Al Batran, Rami; Babu, Mohan; Duong van Hoa, Franck

Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)

来自德国前瞻性 PARAGON(胰腺癌结果、生活质量和转化研究平台)注册研究(IKF-PARAGON 研究)的胰腺癌患者一线至三线治疗情况和生活质量数据

Goetze, Thorsten O; Al-Batran, Salah-Eddin; Liersch, Ruediger; Scheuer, Lars; Goehler, Thomas; Kaiser, Ulrich; Denzlinger, Claudio; Brandl, Stephan; Pink, Daniel; Uhlig, Jens; Maasberg, Michael; Loose, Maria; Schaaf, Marina; Sookthai, Disorn; Zäpf, Bianca; Pauligk, Claudia; Habibzade, Timursah; Hofheinz, Ralf-Dieter; Koch, Christine

Fruquintinib in combination with tislelizumab versus trifluridine/tipiracil and bevacizumab in third-line and beyond MSS mCRC without active liver metastases-the IKF-080/AIO-QUINTIS trial

在无活动性肝转移的MSS mCRC三线及以上治疗中,呋喹替尼联合替雷利珠单抗对比三氟尿苷/替吡嘧啶联合贝伐珠单抗的疗效——IKF-080/AIO-QUINTIS试验

Tintelnot, J; Gorgulho, J; Al-Batran, S-E; Arnold, D; Reinacher-Schick, A; Kasper, S; Prager, G; Goetze, T; Boston, R; Cruz, M S; Dierks, F; Stein, A

Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial

围手术期应用帕博利珠单抗、曲妥珠单抗和FLOT方案治疗HER2阳性局限性食管胃腺癌:一项II期试验

Stein, Alexander; Goekkurt, Eray; Al-Batran, Salah-Eddin; Moosmann, Nicolas; Ettrich, Thomas J; Goetze, Thorsten; Gruen, Barbara; Homann, Nils; Lorenzen, Sylvie; Hofheinz, Ralf-Dieter; Rempel, Viktor; Siegler, Gabriele; Müller, Christian; Thiele, Benjamin; Broering, Tobias; Cruz, Mariana Santos; Pauligk, Claudia; Binder, Mascha; Tintelnot, Joseph

Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy

炎症应激决定接受靶向治疗和免疫治疗的HER2阳性食管胃腺癌患者是否需要化疗

Tintelnot, Joseph; Paschold, Lisa; Goekkurt, Eray; Schultheiss, Christoph; Matschl, Urte; Santos Cruz, Mariana; Bauer, Marcus; Wickenhauser, Claudia; Thuss-Patience, Peter; Lorenzen, Sylvie; Ettrich, Thomas J; Riera-Knorrenschild, Jorge; Jacobasch, Lutz; Kretzschmar, Albrecht; Kubicka, Stefan; Al-Batran, Salah-Eddin; Reinacher-Schick, Anke; Pink, Daniel; Bokemeyer, Carsten; Sinn, Marianne; Lindig, Udo; Hinke, Axel; Hegewisch-Becker, Susanna; Stein, Alexander; Binder, Mascha

Oligometastatic disease - a renaissance for surgery?

寡转移性疾病——外科手术的复兴?

Goetze, Thorsten; Chevallay, Mickael; Dosch, Michel; Marcelis, Jordan; Al-Batran, Salah-Eddin; Mönig, Stefan Paul

First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study

一线纳武利尤单抗和瑞拉利单抗联合化疗治疗胃或胃食管交界处腺癌:II期RELATIVITY-060研究

Hegewisch-Becker, Susanna; Mendez, Guillermo; Chao, Joseph; Nemecek, Radim; Feeney, Kynan; Van Cutsem, Eric; Al-Batran, Salah-Eddin; Mansoor, Wasat; Maisey, Nicholas; Pazo Cid, Roberto; Burge, Matthew; Perez-Callejo, David; Hipkin, R William; Mukherjee, Sourav; Lei, Ming; Tang, Hao; Suryawanshi, Satyendra; Kelly, Ronan J; Tebbutt, Niall C